Wells Fargo & Company MN Has $1.18 Million Stock Position in Hawkins, Inc. (NASDAQ:HWKN)

Wells Fargo & Company MN increased its position in Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 56.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,605 shares of the specialty chemicals company's stock after acquiring an additional 3,485 shares during the quarter. Wells Fargo & Company MN's holdings in Hawkins were worth $1,178,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the company. Blue Trust Inc. grew its position in shares of Hawkins by 155.4% in the fourth quarter. Blue Trust Inc. now owns 355 shares of the specialty chemicals company's stock valued at $44,000 after purchasing an additional 216 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in Hawkins by 262.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 442 shares of the specialty chemicals company's stock valued at $55,000 after buying an additional 320 shares during the last quarter. KBC Group NV increased its position in Hawkins by 37.0% in the 4th quarter. KBC Group NV now owns 948 shares of the specialty chemicals company's stock worth $116,000 after buying an additional 256 shares during the period. Longboard Asset Management LP acquired a new position in shares of Hawkins during the fourth quarter worth approximately $212,000. Finally, Cibc World Markets Corp bought a new stake in shares of Hawkins in the fourth quarter valued at approximately $222,000. Institutional investors own 69.71% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on HWKN. CJS Securities began coverage on shares of Hawkins in a research report on Tuesday, April 1st. They set a "market outperform" rating and a $125.00 target price on the stock. BWS Financial upgraded shares of Hawkins from a "neutral" rating to a "buy" rating and set a $160.00 price objective on the stock in a report on Monday, April 14th.

Hawkins Price Performance

Shares of HWKN stock opened at $123.40 on Tuesday. Hawkins, Inc. has a 12 month low of $71.98 and a 12 month high of $139.55. The company has a market capitalization of $2.58 billion, a P/E ratio of 31.48, a P/E/G ratio of 3.80 and a beta of 0.82. The stock has a 50 day moving average of $109.91 and a two-hundred day moving average of $117.38. The company has a current ratio of 2.50, a quick ratio of 1.53 and a debt-to-equity ratio of 0.23.

Hawkins (NASDAQ:HWKN - Get Free Report) last issued its earnings results on Wednesday, January 29th. The specialty chemicals company reported $0.72 EPS for the quarter, missing the consensus estimate of $0.77 by ($0.05). Hawkins had a return on equity of 18.95% and a net margin of 8.60%. As a group, equities analysts expect that Hawkins, Inc. will post 4 EPS for the current year.

Hawkins Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were paid a $0.18 dividend. The ex-dividend date was Friday, February 14th. This represents a $0.72 dividend on an annualized basis and a yield of 0.58%. Hawkins's payout ratio is currently 18.37%.

Hawkins Company Profile

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.